Stereotaxis (STXS) EBIAT (2016 - 2025)
Stereotaxis (STXS) has disclosed EBIAT for 16 consecutive years, with -$6.5 million as the latest value for Q3 2025.
- On a quarterly basis, EBIAT fell 4.41% to -$6.5 million in Q3 2025 year-over-year; TTM through Sep 2025 was -$23.6 million, a 9.54% decrease, with the full-year FY2024 number at -$24.0 million, down 16.09% from a year prior.
- EBIAT was -$6.5 million for Q3 2025 at Stereotaxis, down from -$3.8 million in the prior quarter.
- In the past five years, EBIAT ranged from a high of -$1.2 million in Q2 2021 to a low of -$7.5 million in Q4 2024.
- A 5-year average of -$4.7 million and a median of -$5.0 million in 2023 define the central range for EBIAT.
- Peak YoY movement for EBIAT: skyrocketed 36.96% in 2021, then crashed 323.95% in 2022.
- Stereotaxis' EBIAT stood at -$3.4 million in 2021, then dropped by 23.82% to -$4.2 million in 2022, then fell by 21.33% to -$5.0 million in 2023, then crashed by 49.11% to -$7.5 million in 2024, then increased by 14.0% to -$6.5 million in 2025.
- Per Business Quant, the three most recent readings for STXS's EBIAT are -$6.5 million (Q3 2025), -$3.8 million (Q2 2025), and -$5.8 million (Q1 2025).